164 related articles for article (PubMed ID: 7355437)
1. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
Ali M; McDonald JW; Thiessen JJ; Coates PE
Stroke; 1980; 11(1):9-13. PubMed ID: 7355437
[TBL] [Abstract][Full Text] [Related]
2. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
Montgomery PR; Sitar DS
Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
[TBL] [Abstract][Full Text] [Related]
3. Human platelet response to three salicylate dosage forms.
Thiessen JJ; Grad H; Macleod SM; Spino M
Biopharm Drug Dispos; 1983; 4(1):43-51. PubMed ID: 6839001
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.
Ross-Lee LM; Elms MJ; Cham BE; Bochner F; Bunce IH; Eadie MJ
Eur J Clin Pharmacol; 1982; 23(6):545-51. PubMed ID: 7160424
[TBL] [Abstract][Full Text] [Related]
5. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
[TBL] [Abstract][Full Text] [Related]
6. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".
Cerletti C; Latini R; Del Maschio A; Galletti F; Dejana E; de Gaetano G
Thromb Haemost; 1985 Jun; 53(3):415-8. PubMed ID: 4049312
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.
Cerletti C; Marchi S; Lauri D; Domanin M; Lorenzi G; Urso R; Dejana E; Latini R; de Gaetano G
Clin Pharmacol Ther; 1987 Aug; 42(2):175-80. PubMed ID: 3301151
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
Roberts MS; McLeod LJ; Cossum PA; Vial JH
Eur J Clin Pharmacol; 1984; 27(1):67-74. PubMed ID: 6436031
[TBL] [Abstract][Full Text] [Related]
10. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
Rao GH; Radh E; Johnson GJ; White JG
Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation and plasma levels of acetylsalicylic acid in stroke patients on long-term treatment with an enteric-coated aspirin formulation.
Britton M; Melander A; Svensson J; Wåhlin-Boll E
Eur J Clin Pharmacol; 1984; 27(3):363-5. PubMed ID: 6510466
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
de Gaetano G; Cerletti C; Dejana E; Latini R
Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
[TBL] [Abstract][Full Text] [Related]
13. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
Mielants H; Verbruggen G; Schelstraete K; Veys EM
J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
[TBL] [Abstract][Full Text] [Related]
14. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
Schwertner HA; McGlasson D; Christopher M; Bush AC
Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
[TBL] [Abstract][Full Text] [Related]
15. Interaction of omeprazole with enteric-coated salicylate tablets.
Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
[TBL] [Abstract][Full Text] [Related]
16. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
Lui CY; Oberle R; Fleisher D; Amidon GL
J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
[TBL] [Abstract][Full Text] [Related]
17. Absorption of salicylate powders versus tablets following overdose: a poison center observational study.
Rose SR; Cumpston KL; Kim J; Difranco D; Wills BK
Clin Toxicol (Phila); 2016 Nov; 54(9):857-861. PubMed ID: 27383649
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
[TBL] [Abstract][Full Text] [Related]
19. Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).
Rehders K; Simrock R; Spahn H; Mutschler E; Breddin HK
Eur J Clin Pharmacol; 1985; 27(6):683-7. PubMed ID: 3987774
[TBL] [Abstract][Full Text] [Related]
20. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
